ClinicalTrialsFinder

Major Depressive Disorder, Recurrent Clinical Trials in Hangzhou, Zhejiang

1 recruitingHangzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Accelerated Intermittent Theta-Burst Stimulation Ameliorate Major Depressive Disorder by Regulating CAMKII Pathway

Major Depressive DisorderMajor Depressive Disorder, Recurrent
First Affiliated Hospital of Zhejiang University90 enrolled1 locationNCT05913960